Bharat Biotech to Initiate Clinical Trials Evaluating Covaxin (India’s First COVID-19 Vaccine) in July 2020

 Bharat Biotech to Initiate Clinical Trials Evaluating Covaxin (India’s First COVID-19 Vaccine) in July 2020

Bharat Biotech to Initiate Clinical Trials Evaluating Covaxin (India’s First COIVD-19 Vaccine) in July 2020

Shots:

  • Bharat Biotech has received DCGI approval to conduct P-I & II clinical studies assessing Covaxin, developed in collaboration with ICMR and NIV. The company anticipate initiating the clinical studies in July’2020
  • The DCGI’s approval is based on preclinical data demonstrating safety and immune response. The SARS-CoV-2 strain was isolated in NIV & transferred to Bharat Biotech
  • The indigenous, inactivated vaccine developed and manufactured in Bharat Biotech’s BSL-3 high containment facility located in Hyderabad, India

Click here to read full press release/ article | Ref: Bharat Biotech | Image: Orissa Diary

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post